Drugs

The European Pharmacovigilance Risk Assessment Committee reviewed reported cases and post-marketing safety data to evaluate the risks of PRES and RCVS with pseudoephedrine-containing medicines.

A review of new launches, new indications, new dosage forms and Health Canada advisories.

Get the info you need on this new product, part of our drug news roundup for September.

Fears of severe reaction to the drug have prevented some providers from prescribing it, but appear to be unwarranted.

Researchers at the University of British Columbia have identified the cellular and molecular mechanisms, induced by a class of antibiotics, that can lead to respiratory allergies.

Systematic review examines pharmacist-led interventions that address improper disposal practices of unused and expired household medications.

Get the info you need on this on new indications for seven existing drugs, part of our drug news roundup for September.

How carefully did you read this recent Health Canada safety review?